Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMapLight Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$1.13 | -$0.88 | -$1.05 |
| Q2 2026 | 5 | -$1.39 | -$1.16 | -$1.31 |
| Q3 2026 | 5 | -$1.43 | -$1.08 | -$1.23 |
| Q4 2026 | 1 | -$1.26 | -$1.26 | -$1.26 |
| Q1 2027 | 1 | -$1.24 | -$1.24 | -$1.24 |
| Q2 2027 | 1 | -$1.19 | -$1.19 | -$1.19 |
| Q3 2027 | 1 | -$1.20 | -$1.20 | -$1.20 |
| Q4 2027 | 1 | -$1.28 | -$1.28 | -$1.28 |
MapLight Therapeutics Inc. Earnings Date And Information
MapLight Therapeutics Inc. last posted its earnings results on Thursday, May 14th, 2026. The company reported $-1.34 earnings per share for the quarter, missing analysts' consensus estimates of $-0.962 by $0.378. The company had revenue of 0 for the quarter and had revenue of 0 for the year. MapLight Therapeutics Inc. has generated $-4 earnings per share over the last year ($-3.66 diluted earnings per share) and currently has a price-to-earnings ratio of -6.5. MapLight Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
MapLight Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2026 | Q1 2026 | -$0.96 | -$1.34 | -0.38 | $0 | $0 |
| 12/30/2025 | Q4 2025 | N/A | -$1.81 | N/A | $0 | $0 |
| 09/30/2025 | Q3 2025 | N/A | -$0.71 | N/A | $0 | $0 |
| 06/29/2025 | Q2 2025 | N/A | -$0.72 | N/A | N/A | $0 |
| 03/30/2025 | Q1 2025 | N/A | -$0.54 | N/A | N/A | $0 |
| 12/31/2024 | Q4 2024 | N/A | -$0.51 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.46 | N/A | N/A | $0 |
| 06/29/2024 | Q2 2024 | N/A | -$0.44 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$0.46 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.29 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MapLight Therapeutics Inc. Earnings: FAQ's
The conference call for MapLight Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for MapLight Therapeutics Inc.'s latest earnings report can be read online.
MapLight Therapeutics Inc. (:MPLT) has a recorded net income of $-161,152,000.MapLight Therapeutics Inc. has generated $-3.66 earnings per share over the last four quarters.
MapLight Therapeutics Inc. (:MPLT) has a price-to-earnings ratio of -6.5 and price/earnings-to-growth ratio is 0.09.